MedPath

The Measurement and Influence of estimated Salt intake in 24-hour urine collection in chrOnic kidneY disease in Okayama Study

Not Applicable
Conditions
chronic kidney disease
Registration Number
JPRN-UMIN000005657
Lead Sponsor
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Brief Summary

The median follow-up period was 36 months, during which time, sixteen of 159 patients reached the renal composite endpoint (10.1%). A significant correlation between the baseline systolic blood pressure and urinary sodium excretion was detected in both all individuals (r=0.2602; P=0.0009) and in female subjects (r=0.3308; P=0.0029). A similar correlation was found between log-transformed value of the baseline urinary protein excretion and urinary sodium excretion in the whole (r=0.1838; P=0.0239) and in the female (r=0.2766; P=0.0136) subjects. When the patients with CKD stage 4 and 5 were stratified according to the quartile levels of urinary sodium excretion of each gender, increase in urinary sodium excretion was a risk for the renal composite endpoint only in female subjects (P=0.0107, Log rank test). In the Cox regression analysis, the level of urinary sodium excretion was independently associated with the endpoint, but the risk was not independent of the urinary protein excretion.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who were lost to follow-up within 90 days from the initiation of observation Patients who already received renal replacement therapy (hemodialysis, peritoneal dialysis and renal transplantation)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
doubling of serum creatinine or introducing of renal replacement therapy
Secondary Outcome Measures
NameTimeMethod
blood pressure, rate of estimated glomerular filtration rate and rate of urinary protein excretion
© Copyright 2025. All Rights Reserved by MedPath